Patents by Inventor Andre Gerard Bubendorf

Andre Gerard Bubendorf has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7772264
    Abstract: The invention is concerned with (S)-1-{[2-(5-Methyl-2-phenyl-oxazol-4-yl)-ethylamino]-acetyl}-pyrrolidine-2-carbonitrile mesylate and crystalline polymorphs of this compound. This compound and its polymorphic forms exhibits superior properties compared to the previously known compounds and can be used as medicament for the treatment of disorders which are associated with DPP-IV.
    Type: Grant
    Filed: March 16, 2006
    Date of Patent: August 10, 2010
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Stefan Abrecht, Andre Gerard Bubendorf, Stephan Goetzoe, Olaf Grassmann, Francois Montavon, Regina Moog, Franziska Rohrer, Armin Ruf, Michelangelo Scalone, Urs Schwitter, Shaoning Wang
  • Patent number: 7148231
    Abstract: The invention is concerned with a novel polymorph of [6,7-Bis(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)amine hydrochloride. This polymorph exhibits superior properties compared to the previously known forms of [6,7-Bis(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)amine hydrochloride. The [6,7-Bis(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)amine hydrochloride is an inhibitor of tyrosine kinase enzymes, and are useful in the treatment of cancer. Also disclosed are methods of making and using the novel polymorph, as well as pharmaceutical compositions containing the novel polymorph.
    Type: Grant
    Filed: February 3, 2004
    Date of Patent: December 12, 2006
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Andre Gerard Bubendorf, Michael Hennig, Pirmin Hidber, Goesta Rimmler, Franziska Rohrer
  • Publication number: 20040198812
    Abstract: The present invention is concerned with pseudopolymorphic forms of 1-(4-carbazolyloxy)-3-[2-(2-methoxyphenoxy)ethylamino]-2-propanole (carvedilol) or of optically active forms or pharmaceutically acceptable salts thereof, processes for the preparation thereof and pharmaceutical compositions containing them.
    Type: Application
    Filed: April 20, 2004
    Publication date: October 7, 2004
    Inventors: Andre Gerard Bubendorf, Rolf-Dieter Gabel, Michael Hennig, Siegfried Krimmer, Guenter Neugebauer, Walter Preis, Alexander Wirl
  • Publication number: 20040162300
    Abstract: The invention is concerned with a novel polymorph of [6,7-Bis(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)amine hydrochloride. This polymorph exhibits superior properties compared to the previously known forms of [6,7-Bis(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)amine hydrochloride. The [6,7-Bis(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)amine hydrochloride is an inhibitor of tyrosine kinase enzymes, and are useful in the treatment of cancer. Also disclosed are methods of making and using the novel polymorph, as well as pharmaceutical compositions containing the novel polymorph.
    Type: Application
    Filed: February 3, 2004
    Publication date: August 19, 2004
    Inventors: Andre Gerard Bubendorf, Michael Hennig, Pirmin Hidber, Goesta Rimmler, Franziska Rohrer
  • Publication number: 20030119893
    Abstract: The present invention is concerned with pseudopolymorphic forms of 1-(4-carbazolyloxy)-3-[2-(2-methoxyphenoxy)ethylamino]-2-propanole (carvedilol) or of optically active forms or pharmaceutically acceptable salts thereof, processes for the preparation thereof and pharmaceutical compositions containing them.
    Type: Application
    Filed: September 26, 2002
    Publication date: June 26, 2003
    Inventors: Andre Gerard Bubendorf, Rolf-Dieter Gabel, Michael Hennig, Siegfried Krimmer, Guenter Neugebauer, Walter Preis, Alexander Wirl